Verseon (Verseon) EV-to-Revenue : (As of Apr. 26, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Verseon EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Verseon's enterprise value is $6,711.05 Mil. Verseon's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00 Mil. Therefore, Verseon's EV-to-Revenue for today is .

The historical rank and industry rank for Verseon's EV-to-Revenue or its related term are showing as below:

VERS's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.68
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-26), Verseon's stock price is $42.0255. Verseon's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00. Therefore, Verseon's PS Ratio for today is .

Verseon EV-to-Revenue Historical Data

The historical data trend for Verseon's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon EV-to-Revenue Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

EV-to-Revenue

Get a 7-Day Free Trial

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
EV-to-Revenue	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Verseon's EV-to-Revenue

For the Biotechnology subindustry, Verseon's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verseon's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verseon's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Verseon's EV-to-Revenue falls into.

Verseon EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Verseon's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	6711.051	/	0
	=

Verseon's current Enterprise Value is $6,711.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Verseon's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00 Mil.

Verseon (GREY:VERS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Verseon's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	42.0255	/	0
	=

Verseon's share price for today is $42.0255.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2019 was $0.00.

Verseon EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Verseon's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (Verseon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.